CytomX Therapeutics, Inc. (CTMX)
NASDAQ·Healthcare·Biotechnology
$4.11
-4.31%
Mkt Cap $757.62M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 16, 2026 | $7.33M | $661.00K | -90.98% | -$0.08 | -$0.22 | -175.00% | — | — |
| Q4 2025 Nov 6, 2025 | $7.33M | $5.96M | -18.59% | -$0.05 | -$0.09 | -82.52% | — | — |
| Q3 2025 Aug 7, 2025 | $18.28M | $18.66M | +2.07% | -$0.06 | -$0.00 | +98.11% | — | — |
| Q2 2025 May 12, 2025 | $35.42M | $50.92M | +43.74% | $0.12 | $0.27 | +116.35% | — | — |
| Q1 2025 Mar 6, 2025 | $13.04M | $38.09M | +192.12% | -$0.23 | $0.22 | +195.65% | — | — |
| Q4 2024 Nov 7, 2024 | $13.53M | $33.43M | +147.03% | -$0.17 | $0.07 | +141.18% | — | — |
| Q3 2024 Aug 8, 2024 | $19.99M | $25.11M | +25.64% | -$0.14 | -$0.08 | +42.86% | — | — |
| Q2 2024 May 8, 2024 | $21.43M | $41.46M | +93.48% | -$0.08 | $0.17 | +312.50% | — | — |
| Q1 2024 Mar 11, 2024 | $21.04M | $26.61M | +26.46% | $0.00 | $0.01 | +134.74% | — | — |
| Q4 2023 Nov 7, 2023 | $20.41M | $26.38M | +29.27% | -$0.19 | $0.04 | +121.05% | — | — |
| Q3 2023 Aug 8, 2023 | $13.88M | $24.72M | +78.13% | -$0.20 | -$0.02 | +90.00% | — | — |
| Q2 2023 May 9, 2023 | $19.59M | $23.50M | +19.95% | -$0.11 | -$0.05 | +54.88% | — | — |
| Q1 2023 Mar 27, 2023 | $17.85M | $20.12M | +12.73% | -$0.24 | -$0.43 | -79.17% | — | — |
| Q4 2022 Nov 8, 2022 | $18.15M | $11.15M | -38.59% | -$0.31 | -$0.35 | -12.90% | — | — |
| Q3 2022 Aug 4, 2022 | $18.11M | $12.85M | -29.05% | -$0.36 | -$0.37 | -2.78% | — | — |
| Q2 2022 May 5, 2022 | $21.25M | $9.04M | -57.45% | -$0.36 | -$0.37 | -2.78% | — | — |
| Q1 2022 Mar 1, 2022 | $19.57M | $19.73M | +0.78% | -$0.28 | -$0.40 | -42.86% | — | — |
| Q4 2021 Nov 4, 2021 | $17.41M | $17.59M | +1.02% | -$0.31 | -$0.35 | -12.90% | — | — |
| Q3 2021 Aug 5, 2021 | $16.29M | $16.29M | +0.00% | -$0.32 | -$0.30 | +6.25% | — | — |
| Q2 2021 May 6, 2021 | $20.08M | $15.97M | -20.45% | -$0.35 | -$0.26 | +25.71% | — | — |